Article
Modulation of bleomycin-induced mitotic recombination in yeast by the aminothiols cysteamine and WR-1065.
Molecular & general genetics : MGG - 10 Dec 1995
Hoffmann G R, Quaranta J L, Shorter R A, Littlefield L G
Abstract excerpt
The cancer chemotherapy drug bleomycin (BLM) is a potent inducer of genetic damage in a wide variety of assays. The radioprotectors cysteamine (CSM) and WR-1065 have been shown in previous studies to potentiate the induction of micronuclei and chromosome aberrations by BLM in Go human lymphocytes. By contrast, WR-1065 is reported to reduce the induction of hprt mutations by BLM in Chinese hamster cells. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
